In clinical practice, patients with NT-proBNP ≥ 450 ng/L had a 2.92-fold incidence of cardiovascular disease or 3.81-fold heart failure compared to individuals with NT-proBNP < 125 ng/L of normal value [11]. This evidence concerns the gene NPPB and cardiovascular disorder.